A nearly 6% drop in the S&P 500 index last week spurred insider buying with insiders purchasing more than 4 times as much stock as they did the prior week, reversing three weeks of declining purchases.
Another week and another deal with big pharma buying out a development stage oncology company. Given the real synergies to be had through young companies partnering with big pharma to leverage their manufacturing expertise and distribution networks, regulators have allowed most of them to go through and they tend to close quickly.
One of the patterns we like to see with insider buying is a long-serving Director of the company purchasing shares opportunistically. If that Director also happens to have an investing background, we like it even better. The cherry on the top is the company also buying back stock on the open market.
In a week where we saw most market indices rebound sharply, insiders scaled back their buying after three weeks of elevated buying. Buying declined by 64% in absolute dollar terms and 26% in terms of the number of companies that saw insider buying.
In another challenging week for the markets where the Nasdaq dropped nearly 4%, insiders once again significantly stepped up their insider purchases for a third week in a row. We saw an increase across all three dimensions, number of unique insiders buying shares, the number of companies with insider buying and the absolute dollar amount of purchases.
Most M&A observers had expected U.S. deal activity to moderate or drop sharply this year but it feels like things are heating up with large acquisitions like Microsoft's acquisition of Activision Blizzard (ATVI) or Elon Musk's acquisition of Twitter (TWTR).
In an unusually volatile week, we saw significant market weakness earlier in the week probably driven by forced selling and a relief rally in the end. Insiders once again stepped up their purchases to take advantage of prices, which in some cases are down anywhere from 50% to 90% from their peaks.
During a highly volatile week for markets, we saw insiders step up and purchase shares, although in aggregate it looked like both insider buying and selling declined compared to the prior week.